Publications
269
Citations
11,766
Est. group size
—
Recurring co-author estimate
Active years
55
Publishing since 1972
Brandy R. Matthews studies Alzheimer's disease and related dementias, with a focus on clinical trials, drug treatments (including amyloid-targeting antibodies), and how to measure meaningful changes in patients. The work also explores patient treatment preferences, disease progression, costs of care, and outcome assessment tools used in research and regulatory decisions.
Publication activity was highest around 2017-2019 and has slowed in recent years, averaging under two publications per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Donanemab in early symptomatic Alzheimer’s disease: results from the TRAILBLAZER-ALZ 2 long-term extension
The Journal of Prevention of Alzheimer s Disease · 2025
- Benefits and risks of FDA‐approved amyloid‐targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician‐patient engagement
Alzheimer s & Dementia · 2024
- Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force
The Journal of Prevention of Alzheimer s Disease · 2024
- Expectations and clinical meaningfulness of randomized controlled trials
Alzheimer s & Dementia · 2023
- Response to van Dyck, O'Dell, & Mecca letter to the editor regarding Andrews et al. (2019)
Alzheimer s & Dementia Translational Research & Clinical Interventions · 2023
- The Patient Voice: Exploring Treatment Preferences in Participants with Mild Cognitive Concerns to Inform Regulatory Decision Making
Patient · 2022
- Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review
Advances in Therapy · 2020
- Pleasurable emotional response to music: A case of neurodegenerative generalized auditory agnosia
Neurocase · 2020
- Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
Alzheimer s & Dementia Translational Research & Clinical Interventions · 2019
- Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease
JAMA Neurology · 2019
- Temporal and Geographic Variation in the Incidence of Alzheimer's Disease Diagnosis in the US between 2007 and 2014
Journal of the American Geriatrics Society · 2019
- P4‐640: DISEASE PROGRESSION AND COSTS AT 1‐YEAR FOLLOW‐UP OF GERAS‐US: A 3‐YEAR STUDY OF MILD COGNITIVE IMPAIRMENT AND MILD DEMENTIA DUE TO ALZHEIMER'S DISEASE IN THE UNITED STATES
Alzheimer s & Dementia · 2019
- P2‐345: DO THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE ESTIMATES FOR CLINICAL OUTCOME ASSESSMENTS FOR ALZHEIMER'S DISEASE DIFFER BY DISEASE SEVERITY?
Alzheimer s & Dementia · 2018
- On the path to 2025: understanding the Alzheimer’s disease continuum
Alzheimer s Research & Therapy · 2017
- Clinicopathological correlations in behavioural variant frontotemporal dementia
Brain · 2017
- Alzheimer s & Dementia×6
- Nature Communications×3
- Scientific Reports×3
- Alzheimer s & Dementia Translational Research & Clinical Interventions×2
- The Journal of Prevention of Alzheimer s Disease×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile